NCT02387203 - Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Pseudomyxoma PeritoneiAppendiceal Neoplasms

Interventions

DRUG

PrevPac (Prevacid, Amoxicillin, Clarithromycin)

30mg Prevacid, 1g amoxicillin, 500mg clarithromycin administered together for oral use, twice daily for 14 days preoperatively and twice daily for 14 days at least 4 weeks postoperatively

Trial Locations (1)

21202

Mercy Medical Center, Baltimore